Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CNCT19 CAR T cells in R/R CD19+ ALL
NCT02975687Phase 1Completed
- Sponsor
- Institute of Hematology and Blood Diseases Hospital
- Start
- Nov 2016
- Primary completion
- Dec 2018
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
Phase 1, open-label trial of inaticabtagene autoleucel in acute lymphoblastic leukemia (ALL), sponsored by Institute of Hematology and Blood Diseases Hospital. Started Nov 2016; status: completed.
02
Drugs
inaticabtagene autoleucel
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT02975687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02975687.